Operating Expenses Cambiamento Data
AstraZeneca USD 10.95B 1.04B 2025-06
Autolus Therapeutics Ltd 82.61M 8.39M 2025-06
Hikma Pharmaceutical USD 1.31B 63M 2024-12
Novartis USD 9.97B 1.02B 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Silence Therapeutics 23.68M 4.76M 2024-09


Autolus Therapeutics Ltd Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.